Biologics Safety Testing Market Report
First published: 15 October 2024 | Last updated: 25 May 2026 | Report Code: biologics-safety-testing
Biologics Safety Testing Market — USD 5.6 billion in 2023, Growing to USD 14.60B by 2033 at 9.7% CAGR
This report provides a comprehensive analysis of the Biologics Safety Testing market, covering market trends, sizes, forecasts up to 2033, and insights into segments and regional performance.
Key Takeaways
- Global market expands from $5.60 Billion in 2023 to $14.60 Billion in 2033, reflecting a 9.7% CAGR for 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe grows from $1.78 Billion in 2023 to $4.64 Billion in 2033, supported by regulatory alignment and testing investments.
- Asia Pacific increases from $1.04 Billion in 2023 to $2.73 Billion in 2033, driven by biologics development and expanded testing capacities.
Biologics Safety Testing Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report examines drivers shaping the biologics safety testing ecosystem, including rising regulatory scrutiny, expanded vaccine and therapeutic pipelines, and investment in advanced testing methods. The market is valued at $5.60 Billion in 2023 and is forecast to reach $14.60 Billion by 2033 at a 9.7% CAGR for 2023 to 2033. Regional dynamics vary: North America leads in absolute scale, while Europe and Asia Pacific show substantial expansion. Service and methodology segmentation highlights demand across in vitro and in vivo approaches, testing and consulting services, and end-users such as pharmaceutical and biotech companies and research institutions. Key players named include Charles River Laboratories, Eurofins Scientific, SGS SA, and LabCorp. The analysis emphasizes ongoing technological adoption, regulatory compliance needs, and the strategic role of specialized testing providers in supporting biologics safety and market access.
Key Growth Drivers
- Stricter regulatory requirements prompting more comprehensive safety testing across vaccines and therapeutics.
- Broader biologics pipelines in pharmaceuticals and biotech firms increasing demand for specialized laboratory services.
- Advances in molecular and in vitro testing methods enabling more efficient safety assessments.
- Rising investments in laboratory capacity and third-party testing services to accelerate product development timelines.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.60 Billion |
| CAGR (2023-2033) | 9.7% |
| 2033 Market Size | $14.60 Billion |
| Top Companies | Charles River Laboratories, Eurofins Scientific, SGS SA, LabCorp |
| Published Date | 15 October 2024 |
| Last Modified Date | 25 May 2026 |
Biologics Safety Testing Market Overview
Customize Biologics Safety Testing Market Report market research report
- ✔ Get in-depth analysis of Biologics Safety Testing market size, growth, and forecasts.
- ✔ Understand Biologics Safety Testing's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Biologics Safety Testing
What is the Market Size & CAGR of Biologics Safety Testing Market Report market in 2023?
Biologics Safety Testing Industry Analysis
Biologics Safety Testing Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Biologics Safety Testing Market Report Market Analysis Report by Region
Europe Biologics Safety Testing Market Report:
Europe grows from $1.78 Billion in 2023 to $4.64 Billion in 2033. 78 Billion in 2023 to $4.64 Billion in 2033, driven by coordinated regulatory frameworks and investments in laboratory capacity. Regional expansion is supported by active pharmaceutical and biotech sectors seeking compliant safety testing.Asia Pacific Biologics Safety Testing Market Report:
Asia Pacific grows from $1.04 Billion in 2023 to $2.73 Billion in 2033. 04 Billion in 2023 to $2.73 Billion in 2033 as biologics development accelerates and testing service networks scale. Increasing local manufacturing and clinical activity contribute to higher demand for safety assessments.North America Biologics Safety Testing Market Report:
North America is largest regional market, rising from $1.97 Billion in 2023 to $5.13 Billion in 2033. This scale reflects substantial testing infrastructure, high biologics development activity, and strong regulatory enforcement supporting demand for specialized safety services.South America Biologics Safety Testing Market Report:
Latin America grows from $0.35 Billion in 2023 to $0.92 Billion in 2033. 35 Billion in 2023 to $0.92 Billion in 2033, reflecting gradual expansion of testing capabilities and growing regional participation in biologics development that necessitates safety verification.Middle East & Africa Biologics Safety Testing Market Report:
Middle East and Africa grows from $0.45 Billion in 2023 to $1.18 Billion in 2033. 45 Billion in 2023 to $1.18 Billion in 2033, supported by incremental investments in laboratory infrastructure and rising regulatory attention to biologic product safety across the region.Tell us your focus area and get a customized research report.
Research Methodology
Biologics Safety Testing Market Analysis By Methodology
The segment analysis highlights a significant reliance on in vitro testing, which dominates the market with a size of $4.77 billion in 2023, expected to grow to $12.45 billion by 2033. In vivo testing, though smaller, shows substantial growth potential, expanding from $0.83 billion to $2.16 billion in the same period.
Biologics Safety Testing Market Analysis By Product Type
Vaccines make up a substantial portion of the market, growing from $4.77 billion in 2023 to $12.45 billion by 2033. Therapeutics and diagnostics are also critical, showing a rising demand as they play a vital role in compliance with safety standards.
Biologics Safety Testing Market Analysis By Service Type
Testing services encompass the majority of the market share, with significant contributions from consulting services. Testing services are set to increase from $4.77 billion in 2023 to $12.45 billion in 2033, asserting their importance in the industry.
Biologics Safety Testing Market Analysis By End User
Pharmaceutical and biotech companies lead the end-user segment, with a market size of $3.61 billion expected to reach $9.42 billion by 2033. Research institutions also play a significant role, with revenues projected to rise from $0.62 billion to $1.62 billion.
Biologics Safety Testing Market Analysis By Region Specific
Various regional factors uniquely influence market growth. North America drives innovation due to mature infrastructure, while Asia Pacific benefits from rapid expansion in production capabilities. Regulatory challenges in Europe also indicate essential regional comparisons.
Biologics Safety Testing Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Biologics Safety Testing Industry
Charles River Laboratories:
A leading provider of preclinical and clinical laboratory services for the biopharmaceutical industry, Charles River is essential in providing comprehensive safety testing services.Eurofins Scientific:
Specializing in bioanalytical testing, Eurofins offers a range of services necessary for biologics safety testing, helping pharmaceutical companies ensure their products meet regulatory compliance.SGS SA:
With a global presence, SGS provides inspection, verification, testing, and certification services, including crucial testing for biologics to ensure compliance and safety.LabCorp:
LabCorp plays a significant role in laboratory testing and provides comprehensive solutions for biologics safety assessment, supporting the development pipeline of many medications.We're grateful to work with incredible clients.
FAQs
What is the market size of the Biologics Safety Testing Market Report in 2023?
The market size for 2023 is $5.60 Billion, as reported in the input data, reflecting the baseline for the 2023 to 2033 forecast period.
How big will the biologics safety testing market be in 2033?
By 2033 the market is projected to reach $14.60 Billion according to the provided forecast figures for the 2023 to 2033 period.
What is CAGR for the forecast period?
The compound annual growth rate for 2023 to 2033 is 9.7%, as specified in the input market metrics.
Is there a single fastest Growing region in the Biologics Safety Testing Market Report market?
No single fastest-growing region is stated for the Biologics Safety Testing Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as key players?
Top companies named in the input include Charles River Laboratories, Eurofins Scientific, SGS SA, and LabCorp.
What end Users drive demand for testing services?
Primary end-users include pharmaceutical companies, biotech companies, and research institutions, each requiring safety testing for biologic products.
How are testing methodologies categorized in the report?
Methodology segmentation includes in vitro testing and in vivo testing, reflecting common laboratory approaches for biologics safety assessment.
What types of services are covered?
Service categories in the input comprise testing services and consulting services, addressing laboratory execution and advisory needs.
Who conducted the research?
Research methods include primary interviews with industry experts and secondary review of company reports and publications, combined with data triangulation.
What is driving demand in Asia Pacific?
Asia Pacific growth is linked to expanding biologics development and increased testing capacity, with the region rising from $1.04 Billion in 2023 to $2.73 Billion in 2033.